谷歌浏览器插件
订阅小程序
在清言上使用

Mechanism of Non-Competitive Inhibition of the SARS-CoV-2 3CL Protease Dimerization: Therapeutic and Clinical Promise of the Lichen Secondary Metabolite Perlatolinic Acid

Heliyon(2024)

引用 0|浏览4
关键词
SARS-CoV-2 3CL protease inhibition,Perlatolinic acid antiviral activity,Lichen metabolites against COVID-19,3CL protease dimer interface,Broad-spectrum COVID-19 therapeutics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要